UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. URGN currently screens at market cap $1.61B.
Use this URGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the URGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the URGN SEC filings page. Lician reads the product cache first so this HTML stays unique to UroGen Pharma Ltd even when a live quote feed is slow.
Latest cached year on this hub. Full URGN income, balance, and cash tables.